Skip to main content
Overview
News
Events & Presentations
Stock Information
Why Invest
Stock Quote
Stock Chart
Historical Stock Quote
Analyst Coverage
Financials
Financial Overview
Sedar Filings
Governance
Executive Management
Board of Directors
Governance Documents
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Overview
News
Events & Presentations
Stock Information
Why Invest
Stock Quote
Stock Chart
Historical Stock Quote
Analyst Coverage
Financials
Financial Overview
Sedar Filings
Governance
Executive Management
Board of Directors
Governance Documents
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Overview
Investor Relations
Overview
News
Events & Presentations
Stock Information
Why Invest
Stock Quote
Stock Chart
Historical Stock Quote
Analyst Coverage
Financials
Financial Overview
Sedar Filings
Governance
Executive Management
Board of Directors
Governance Documents
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contacts
Why Invest
Numinus is at the forefront of the mental health care revolution, with proprietary, psychedelic-centered, therapeutic products and services
Learn More
Management
Numinus is led by scientific, medical and business leaders whose expertise spans international healthcare research, policy reform, regulatory affairs, capital markets, technology, and government relations.
Learn More
Stock Information
Numinus went public on May 20, 2020 and is traded on the TSX exchange, under the symbol NUMI.
Learn more
Latest News
View all news
Latest Events & Presentation
View All events
More results